Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

** = Publikationen gelistet in SCI/SSCI/Pubmed

** Hechenberger, S; Helmlinger, B; Fruhwirth, V; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Pinter, D Evaluation of a Self-administered, IPad-based Processing Speed Test for People with Multiple Sclerosis
MULT SCLER J. 2022; 28(2_SUPPL): 12-13. [Poster]
Web of Science

** Hechenberger, S; Pirpamer, L; Fruhwirth, V; Berger, L; Helmlinger, B; Wurth, S; Damulina, A; Eppinger, S; Khalil, M; Enzinger, C; Penner, I; Pinter, D Structural Brain Changes Associated with Fatigue in People with Multiple Sclerosis
EUR J NEUROL. Proceedings of the 8th Congress of the EAN. 2022; 29: 222-222.-8th Congress of the European-Academy-of-Neurology (EAN); JUN 25-28, 2022; Vienna, AUSTRIA. [Poster]
Web of Science

** Hechenberger, S; Pirpamer, L; Helmlinger, B; Fruhwirth, V; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Penner, IK; Pinter, D Factors influencing fatigue in persons with multiple sclerosis: contribution of psychological and magnetic resonance imaging assessment
MULT SCLER J. 2022; 28(3_SUPPL): 436-437. [Poster]
Web of Science FullText

** Helmlinger, B; Hechenberger, S; Fruhwirth, V; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Pinter, D Self-efficacy influences depression and anxiety in a cross-sectional cohort of people with multiple sclerosis
MULT SCLER J. 2022; 28(3_SUPPL):907-907.-38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis; OCT 26-28, 2022; Amsterdam, NETHERLANDS. [Poster]
Web of Science

** Auer, M; Zinganell, A; Hegen, H; Bsteh, G; Di Pauli, F; Berek, K; Fava, E; Wurth, S; Berger, T; Deisenhammer, F Experiences in treatment of multiple sclerosis with natalizumab from a real-life cohort over 15 years
SCI REP-UK. 2021; 11(1): 23317 Doi: 10.1038/s41598-021-02665-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Bsteh, G; Berek, K; Hegen, H; Altmann, P; Wurth, S; Auer, M; Zinganell, A; Di Pauli, F; Rommer, P; Leutmezer, F; Deisenhammer, F; Berger, T Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis.
Mult Scler. 2021; 27(5):684-694 Doi: 10.1177/1352458520935724
Web of Science PubMed FullText FullText_MUG

** Auer, M; Zinganell, A; Hegen, H; Bsteh, G; Di Pauli, F; Berek, K; Fava, E; Wurth, S; Berger, T; Deisenhammer, F Treatment of multiple sclerosis with natalizumab: experiences from a real-life cohort over 15 years
MULT SCLER J. ECTRIMS 2021 Abstracts. 2021; 27(2_SUPPL):588-588.-37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; OCT 13-15, 2021; Vienna, AUSTRIA. [Poster]
Web of Science

** Bsteh, G; Hegen, H; Berek, K; Altmann, P; Auer, M; Di Pauli, F; Leutmezer, F; Rommer, P; Wurth, S; Zinganell, A; Deisenhammer, F; Berger, T Olfactory threshold predicts treatment response in relapsing multiple sclerosis
MULT SCLER J. ECTRIMS 2021 Abstracts. 2021; 27(2_SUPPL):53-53.-37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; OCT 13-15, 2021; Vienna, AUSTRIA. [Poster]
Web of Science

** Hegen, H; Berek, K; Bsteh, G; Auer, M; Di Pauli, F; Grams, A; Milosavljevic, D; Poskaite, P; Schnabl, C; Wurth, S; Zinganell, A; Berger, T; Walde, J; Deisenhammer, F Kappa free light chains in cerebrospinal fluid predict early multiple sclerosis disease activity
MULT SCLER J. ECTRIMS 2021 Abstracts. 2021; 27(2_SUPPL):505-506.-37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; OCT 13-15, 2021; Vienna, AUSTRIA. [Poster]
Web of Science

** Bsteh, G; Hegen, H; Altmann, P; Auer, M; Berek, K; Di Pauli, F; Wurth, S; Zinganell, A; Rommer, P; Deisenhammer, F; Leutmezer, F; Berger, T Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis
MULT SCLER J-EXP TRA. 2020; 6(4): 2055217320966344 Doi: 10.1177/2055217320966344 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Auer, M; Bsteh, G; Hegen, H; Wurth, S; Zinganell, A; Berger, T; Deisenhammer, F; Pauli, FD Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab.
Mult Scler Relat Disord. 2020; 43(8):102155-102155 Doi: 10.1016/j.msard.2020.102155
Web of Science PubMed FullText FullText_MUG

** Berek, K; Fava, E; Zinganell, A; Hegen, H; Auer, M; Wurth, S; Rhomberg, P; Deisenhammer, F; Di Pauli, F Transverse myelitis as a rare presentation of antiphospholipid-antibody-associated disorders.
Mult Scler Relat Disord. 2020; 45(10):102405-102405 Doi: 10.1016/j.msard.2020.102405 (- Case Report)
Web of Science PubMed FullText FullText_MUG

** Auer, M; Bsteh, G; Hegen, H; Wurth, S; Zinganell, A; Berger, T; Deisenhammer, F; Di Pauli, F Late-onset neutropenia in a multiple sclerosis patient after first dose ocrelizumab switched from rituximab.
MULT SCLER J. 2020; 26(3_SUPPL): 287-287. [Poster]
Web of Science